303 related articles for article (PubMed ID: 18246411)
1. A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.
Arnold HK; Sears RC
Cancer Metastasis Rev; 2008 Jun; 27(2):147-58. PubMed ID: 18246411
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.
Arnold HK; Sears RC
Mol Cell Biol; 2006 Apr; 26(7):2832-44. PubMed ID: 16537924
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model.
Janghorban M; Langer EM; Wang X; Zachman D; Daniel CJ; Hooper J; Fleming WH; Agarwal A; Sears RC
PLoS One; 2017; 12(11):e0188910. PubMed ID: 29190822
[TBL] [Abstract][Full Text] [Related]
4. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
[TBL] [Abstract][Full Text] [Related]
5. PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.
Ruvolo VR; Kurinna SM; Karanjeet KB; Schuster TF; Martelli AM; McCubrey JA; Ruvolo PP
J Biol Chem; 2008 Dec; 283(51):35474-85. PubMed ID: 18957415
[TBL] [Abstract][Full Text] [Related]
6. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
[TBL] [Abstract][Full Text] [Related]
8. Identification of PP2A complexes and pathways involved in cell transformation.
Sablina AA; Hector M; Colpaert N; Hahn WC
Cancer Res; 2010 Dec; 70(24):10474-84. PubMed ID: 21159657
[TBL] [Abstract][Full Text] [Related]
9. PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.
Mannava S; Omilian AR; Wawrzyniak JA; Fink EE; Zhuang D; Miecznikowski JC; Marshall JR; Soengas MS; Sears RC; Morrison CD; Nikiforov MA
Oncogene; 2012 Mar; 31(12):1484-92. PubMed ID: 21822300
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.
Little SC; Curran J; Makara MA; Kline CF; Ho HT; Xu Z; Wu X; Polina I; Musa H; Meadows AM; Carnes CA; Biesiadecki BJ; Davis JP; Weisleder N; Györke S; Wehrens XH; Hund TJ; Mohler PJ
Sci Signal; 2015 Jul; 8(386):ra72. PubMed ID: 26198358
[TBL] [Abstract][Full Text] [Related]
11. PP2A: unveiling a reluctant tumor suppressor.
Mumby M
Cell; 2007 Jul; 130(1):21-4. PubMed ID: 17632053
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling.
Cai Z; Zhang W; Zhou R; Wang Y; Feng Y
Cell Biochem Biophys; 2023 Mar; 81(1):59-68. PubMed ID: 36324030
[TBL] [Abstract][Full Text] [Related]
13. Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A.
Pavic K; Gupta N; Omella JD; Derua R; Aakula A; Huhtaniemi R; Määttä JA; Höfflin N; Okkeri J; Wang Z; Kauko O; Varjus R; Honkanen H; Abankwa D; Köhn M; Hytönen VP; Xu W; Nilsson J; Page R; Janssens V; Leitner A; Westermarck J
Nat Commun; 2023 Feb; 14(1):1143. PubMed ID: 36854761
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A regulatory subunits and cancer.
Eichhorn PJ; Creyghton MP; Bernards R
Biochim Biophys Acta; 2009 Jan; 1795(1):1-15. PubMed ID: 18588945
[TBL] [Abstract][Full Text] [Related]
15. Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc.
Raman D; Chong SJF; Iskandar K; Hirpara JL; Pervaiz S
Redox Biol; 2020 Jul; 34():101587. PubMed ID: 32512497
[TBL] [Abstract][Full Text] [Related]
16. Regulation and role of the PP2A-B56 holoenzyme family in cancer.
Peris I; Romero-Murillo S; Vicente C; Narla G; Odero MD
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188953. PubMed ID: 37437699
[TBL] [Abstract][Full Text] [Related]
17. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
[TBL] [Abstract][Full Text] [Related]
18. B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer.
Tan J; Lee PL; Li Z; Jiang X; Lim YC; Hooi SC; Yu Q
Cancer Cell; 2010 Nov; 18(5):459-71. PubMed ID: 21075311
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
Farrington CC; Yuan E; Mazhar S; Izadmehr S; Hurst L; Allen-Petersen BL; Janghorban M; Chung E; Wolczanski G; Galsky M; Sears R; Sangodkar J; Narla G
J Biol Chem; 2020 Jan; 295(3):757-770. PubMed ID: 31822503
[TBL] [Abstract][Full Text] [Related]
20. Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo.
Lambrecht C; Libbrecht L; Sagaert X; Pauwels P; Hoorne Y; Crowther J; Louis JV; Sents W; Sablina A; Janssens V
Oncogene; 2018 Jan; 37(4):544-552. PubMed ID: 28967903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
